 Glaukos Corporation NYSE: GKOS, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that in light of the companys offering of its 2.75 Convertible Senior Notes due 2027, which is expected to close on June 11, 2020, subject to customary closing conditions, management will no longer be participating in its previously announced virtual fireside presentation and associated webcast at the William Blair 40th Annual Growth Stock Conference, previously scheduled for Wednesday, June 10, 2020, at 3:20 p.m. CDT. Management will continue to participate in the conferences other investor forums. 